Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Lisa König
Fabian D. Mairinger
Oliver Hoffmann
Ann-Kathrin Bittner
Kurt W. Schmid
Rainer Kimmig
Sabine Kasimir-Bauer
Agnes Bankfalvi
机构：
[1] University Hospital Essen,Department of Gynecology and Obstetrics
[2] University of Duisburg-Essen,Institute for Pathology
[3] University Hospital Essen,undefined
[4] University of Duisburg-Essen,undefined
来源：
BMC Cancer | / 19卷
关键词：
Breast cancer; Tumor-infiltrating lymphocytes; Tumor microenvironment; Neoadjuvant chemotherapy; Minimal residual disease; Disseminated tumor cells; T cells; B cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Predictive value of stromal tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant chemotherapy: A meta-analysis
    Xia, Guangfa
    Zhang, Ziran
    Jiang, Qin
    Wang, Huan
    Wang, Jie
    MEDICINE, 2024, 103 (06) : E36810
  • [42] Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
    A. Marijne Heeren
    Iske F. van Luijk
    Joost Lakeman
    Noëlle Pocorni
    Jeroen Kole
    Renée X. de Menezes
    Gemma G. Kenter
    Tjalling Bosse
    Cornelis D. de Kroon
    Ekaterina S. Jordanova
    Cancer Immunology, Immunotherapy, 2019, 68 : 1759 - 1767
  • [43] Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
    Heeren, A. Marijne
    van Luijk, Iske F.
    Lakeman, Joost
    Pocorni, Noelle
    Kole, Jeroen
    de Menezes, Renee X.
    Kenter, Gem Ma G.
    Bosse, Tjalling
    de Kroon, Cornelis D.
    Jordanova, Ekaterina S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (11) : 1759 - 1767
  • [44] Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer
    Oner, Gizem
    Praet, Marleen Marguerite
    Stoop, Hans
    Devi, Gayathri R.
    Canturk, Nuh Zafer
    Altintas, Sevilay
    Van Berckelaer, Christophe
    Berneman, Zwi
    Tjalma, Wiebren
    Koljenovic, Senada
    Dam, Peter A. van
    BREAST CANCER-TARGETS AND THERAPY, 2025, 17 : 211 - 224
  • [45] Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
    Mani, Nikita L.
    Schalper, Kurt A.
    Hatzis, Christos
    Saglam, Ozlen
    Tavassoli, Fattaneh
    Butler, Meghan
    Chagpar, Anees B.
    Pusztai, Lajos
    Rimm, David L.
    BREAST CANCER RESEARCH, 2016, 18
  • [46] Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
    Nikita L. Mani
    Kurt A. Schalper
    Christos Hatzis
    Ozlen Saglam
    Fattaneh Tavassoli
    Meghan Butler
    Anees B. Chagpar
    Lajos Pusztai
    David L. Rimm
    Breast Cancer Research, 18
  • [47] Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
    Solinas, Cinzia
    Carbognin, Luisa
    De Silva, Pushpamali
    Criscitiello, Carmen
    Lambertini, Matteo
    BREAST, 2017, 35 : 142 - 150
  • [48] Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy
    Walter, Vincent P.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Hahn, Markus
    Brucker, Sara Y.
    Hartkopf, Andreas D.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (03) : 785 - 790
  • [49] Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
    Nelson, Molly A.
    Ngamcherdtrakul, Worapol
    Luoh, Shiuh-Wen
    Yantasee, Wassana
    CANCER AND METASTASIS REVIEWS, 2021, 40 (02) : 519 - 536
  • [50] Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
    Yee, Elliott J.
    Gilbert, Danielle
    Kaplan, Jeffrey
    Wani, Sachin
    Kim, Sunnie S.
    McCarter, Martin D.
    Stewart, Camille L.
    CANCERS, 2024, 16 (07)
12345